Vanderbilt University Professor Stacie News Today : Breaking News, Live Updates & Top Stories | Vimarsana

At least four drugmakers are expected to launch new copycat versions of AbbVie's top-selling rheumatoid arthritis drug, Humira, over the next week, but experts expect little change in prices for the treatment even with the new competition. Drugmakers Boehringer Ingelheim, Sandoz and Organon are expected to launch their biosimilars on Saturday, adding to U.S. competition for the drug that started when Amgen released its copy in January. Usually prices fall, often dramatically, when multiple generic versions of a widely used medication enter market. ....

United States , New York , Stephen Pagnotta , Boehringer Ingelheim , Patrick Wingrove , Matthew Lewis , Coherus Biosciences , Robert Popovian , Mark Cuban , Michele Gershberg , Unitedhealth Group Optum , Care Management Association , Health Corp , Global Healthy Living Foundation , Cigna Group Express Scripts , Vanderbilt University Professor Stacie Dusetzina , South Korea , Vanderbilt University Professor Stacie , Cigna Group , Express Scripts , Unitedhealth Group , Pharmaceutical Care Management Association , Biologic Drugs ,